Steven Habraken

Papers

Total Citations

H-Index

About

Steven Habraken is a leading researcher in radiation oncology, with a primary focus on optimizing treatment planning to minimize long-term risks for cancer patients. His key research areas include accelerated partial breast irradiation (APBI) and the mitigation of radiation-induced secondary malignancies. Habraken’s most notable contribution is his work on reducing the risk of secondary lung cancer in APBI treatment planning. His 2020 study, which has garnered 7 citations, demonstrated that lowering lung dose during adjuvant radiotherapy for low-risk breast cancer can offset the potential survival benefit lost to radiation-induced lung cancer. This work highlights a critical trade-off in modern oncology: balancing local recurrence control with the risk of late effects. Habraken’s research is particularly impactful for clinicians and physicists designing safer, more personalized breast cancer treatments. His findings underscore the importance of advanced planning techniques, such as intensity-modulated radiotherapy and deep inspiration breath-hold, to spare healthy lung tissue. For students and researchers, Habraken’s work serves as a model for integrating dosimetric analysis with long-term patient outcomes, advancing the field toward more survivorship-focused care.